Leukemia Clinical Trials in Illinois

Showing 1401-1420 of 1,750 trials

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01868893

This is a multicenter, open-label, single-arm, expanded access treatment study designed to provide obinutuzumab to patients with previously untreated Chronic Lymphocytic Leukemia (CLL) in combination with chlorambucil and to evaluate the safety and efficacy of obinutuzumab administered in combination with chlorambucil. This study will enroll patients with previously untreated CD20-positive CLL requiring treatment according to the IWCLL guidelines (Hallek et al 2008), as assessed by the investigator.

Chronic Lymphocytic Leukemia

Genentech, Inc.20 participantsStarted Aug 2013

Huntsville, Alabama, United States • Rogers, Arkansas, United States • La Jolla, California, United States +16 more locations

COMPLETEDPhase 2114 miles

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

NCT01160601

This is a randomized, open-label, multicenter, phase 2 study comparing Paclitaxel/Carboplatin with or without bavituximab in patients that have previously untreated locally advanced or metastatic non-small cell lung cancer (NSCLC).

Non-Squamous Non-Small Cell Lung Cancer

Peregrine Pharmaceuticals86 participantsStarted Jun 2010

Chandler, Arizona, United States • Jonesboro, Arkansas, United States • Whittier, California, United States +37 more locations

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

Leukemia Trials in Other Cities

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

CNDO-109-AANK for AML in First Complete Remission (CR1)

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer

Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung Cancer

Early Blood Pressure Management in Extremely Premature Infants

Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects

Weaning And Variability Evaluation

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC

A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors

Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma

Evaluating Processes of Care & the Outcomes of Children in Hospital (EPOCH)

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies

Other Conditions in Illinois